Related Experiment Video
Updated: May 10, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Paediatric Systemic Lupus Erythematosus with chronic diarrhea as an initial presentation
Ali Abdur Rahman1, Asfand Tariq2
1Ali Abdur Rahman, Department of Paediatric Medicine, Shaikh Zayed Hospital, Lahore, Pakistan.
Lupus enteritis (LE), a rare Childhood Systemic Lupus Erythematosus (cSLE) manifestation, presents with non-specific gastrointestinal symptoms. Early diagnosis and treatment of LE in children are crucial for preventing severe complications and ensuring a good prognosis.
Area of Science:
- Pediatric Rheumatology
- Gastroenterology
Background:
- Childhood Systemic Lupus Erythematosus (cSLE) is a chronic autoimmune disease with diverse clinical manifestations.
- Lupus enteritis (LE) is an uncommon gastrointestinal complication of cSLE, often presenting insidiously.
Observation:
- The patient presented with non-specific gastrointestinal symptoms, including loose motions, abdominal pain, nausea, and vomiting.
- Diagnosis of LE was challenging due to the absence of other typical cSLE features, requiring thorough investigation.
- The patient showed a positive response to initial management strategies.
Findings:
- Lupus enteritis is a rare but significant manifestation in pediatric patients with cSLE.
- Non-specific abdominal symptoms can be the sole presenting feature of LE, complicating early diagnosis.
- Prompt diagnosis and management are essential for mitigating severe complications.
Implications:
- Highlights the importance of considering LE in children with unexplained gastrointestinal issues, even without overt SLE signs.
- Emphasizes the potential for severe gastrointestinal complications like bleeding, perforation, and infarction in pediatric LE.
- Underscores that early intervention in LE leads to favorable outcomes and improved prognosis in children.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

